These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
230 related articles for article (PubMed ID: 18034418)
1. Manipulation of NK cytotoxicity by the IAP family member Livin. Nachmias B; Mizrahi S; Elmalech M; Lazar I; Ashhab Y; Gazit R; Markel G; Ben-Yehuda D; Mandelboim O Eur J Immunol; 2007 Dec; 37(12):3467-76. PubMed ID: 18034418 [TBL] [Abstract][Full Text] [Related]
2. The inhibitor of apoptosis protein Livin (ML-IAP) plays a dual role in tumorigenicity. Abd-Elrahman I; Hershko K; Neuman T; Nachmias B; Perlman R; Ben-Yehuda D Cancer Res; 2009 Jul; 69(13):5475-80. PubMed ID: 19549891 [TBL] [Abstract][Full Text] [Related]
3. Aberrant expression and potency as a cancer immunotherapy target of inhibitor of apoptosis protein family, Livin/ML-IAP in lung cancer. Hariu H; Hirohashi Y; Torigoe T; Asanuma H; Hariu M; Tamura Y; Aketa K; Nabeta C; Nakanishi K; Kamiguchi K; Mano Y; Kitamura H; Kobayashi J; Tsukahara T; Shijubo N; Sato N Clin Cancer Res; 2005 Feb; 11(3):1000-9. PubMed ID: 15709165 [TBL] [Abstract][Full Text] [Related]
4. [Effects of gene Livin transfection affect on the apoptosis in bladder carcinoma cells]. Liu XK; Liu HB; Kong CZ Zhonghua Yi Xue Za Zhi; 2008 Mar; 88(12):853-5. PubMed ID: 18756993 [TBL] [Abstract][Full Text] [Related]
5. Livin promotes Smac/DIABLO degradation by ubiquitin-proteasome pathway. Ma L; Huang Y; Song Z; Feng S; Tian X; Du W; Qiu X; Heese K; Wu M Cell Death Differ; 2006 Dec; 13(12):2079-88. PubMed ID: 16729033 [TBL] [Abstract][Full Text] [Related]
6. The anti-apoptotic livin gene is an important determinant for the apoptotic resistance of non-small cell lung cancer cells. Crnković-Mertens I; Muley T; Meister M; Hartenstein B; Semzow J; Butz K; Hoppe-Seyler F Lung Cancer; 2006 Nov; 54(2):135-42. PubMed ID: 16965834 [TBL] [Abstract][Full Text] [Related]
7. Caspase-mediated cleavage converts Livin from an antiapoptotic to a proapoptotic factor: implications for drug-resistant melanoma. Nachmias B; Ashhab Y; Bucholtz V; Drize O; Kadouri L; Lotem M; Peretz T; Mandelboim O; Ben-Yehuda D Cancer Res; 2003 Oct; 63(19):6340-9. PubMed ID: 14559822 [TBL] [Abstract][Full Text] [Related]
8. Silencing Livin gene expression to inhibit proliferation and enhance chemosensitivity in tumor cells. Wang R; Lin F; Wang X; Gao P; Dong K; Zou AM; Cheng SY; Wei SH; Zhang HZ Cancer Gene Ther; 2008 Jun; 15(6):402-12. PubMed ID: 18340356 [TBL] [Abstract][Full Text] [Related]
9. Inhibitor of apoptosis proteins are regulated by tumour necrosis factor-alpha in malignant pleural mesothelioma. Gordon GJ; Mani M; Mukhopadhyay L; Dong L; Yeap BY; Sugarbaker DJ; Bueno R J Pathol; 2007 Mar; 211(4):439-46. PubMed ID: 17253597 [TBL] [Abstract][Full Text] [Related]
10. Livin-α promotes cell proliferation by regulating G1-S cell cycle transition in prostate cancer. Ye L; Song X; Li S; Yang D; Zhang J; Che X; Chen X; Wang J; Zhang Z Prostate; 2011 Jan; 71(1):42-51. PubMed ID: 20607788 [TBL] [Abstract][Full Text] [Related]
11. Antitumor effects of murine bone marrow-derived dendritic cells infected with xenogeneic livin alpha recombinant adenoviral vectors against Lewis lung carcinoma. Xie J; Xiong L; Tao X; Li X; Su Y; Hou X; Shi H Lung Cancer; 2010 Jun; 68(3):338-45. PubMed ID: 19671483 [TBL] [Abstract][Full Text] [Related]
12. Silencing livin gene by siRNA leads to apoptosis induction, cell cycle arrest, and proliferation inhibition in malignant melanoma LiBr cells. Wang H; Tan SS; Wang XY; Liu DH; Yu CS; Bai ZL; He DL; Zhao J Acta Pharmacol Sin; 2007 Dec; 28(12):1968-74. PubMed ID: 18031611 [TBL] [Abstract][Full Text] [Related]
13. Induction of apoptosis in tumor cells by siRNA-mediated silencing of the livin/ML-IAP/KIAP gene. Crnkovic-Mertens I; Hoppe-Seyler F; Butz K Oncogene; 2003 Nov; 22(51):8330-6. PubMed ID: 14614456 [TBL] [Abstract][Full Text] [Related]
14. Subcellular localization determines the delicate balance between the anti- and pro-apoptotic activity of Livin. Nachmias B; Lazar I; Elmalech M; Abed-El-Rahaman I; Asshab Y; Mandelboim O; Perlman R; Ben-Yehuda D Apoptosis; 2007 Jul; 12(7):1129-42. PubMed ID: 17294084 [TBL] [Abstract][Full Text] [Related]
15. [Gene transfection of Livin isoforms into A549 cell line and its effect on cell growth and sensitivity to chemotherapy and radiotherapy]. Sun JG; Liao RX; Chen ZT; Wang ZX; Zhang Q; Hu YD; Wang DL Zhonghua Jie He He Hu Xi Za Zhi; 2005 Dec; 28(12):836-40. PubMed ID: 16409786 [TBL] [Abstract][Full Text] [Related]
16. Livin may serve as a marker for prognosis of bladder cancer relapse and a target of bladder cancer treatment. Liu HB; Kong CZ; Zeng Y; Liu XK; Bi JB; Jiang YJ; Han S Urol Oncol; 2009; 27(3):277-83. PubMed ID: 18555709 [TBL] [Abstract][Full Text] [Related]
17. KHYG-1, a model for the study of enhanced natural killer cell cytotoxicity. Suck G; Branch DR; Smyth MJ; Miller RG; Vergidis J; Fahim S; Keating A Exp Hematol; 2005 Oct; 33(10):1160-71. PubMed ID: 16219538 [TBL] [Abstract][Full Text] [Related]
18. Selective loss of NK cytotoxicity in antisense NK-TR1 rat LGL cell lines. Abrogation of antibody-independent tumor and virus-infected target cell killing. Giardina SL; Anderson SK; Sayers TJ; Chambers WH; Palumbo GA; Young HA; Ortaldo JR J Immunol; 1995 Jan; 154(1):80-7. PubMed ID: 7995961 [TBL] [Abstract][Full Text] [Related]
19. Livin/ML-IAP as a new target for cancer treatment. Liu B; Han M; Wen JK; Wang L Cancer Lett; 2007 Jun; 250(2):168-76. PubMed ID: 17218055 [TBL] [Abstract][Full Text] [Related]
20. 2-D DIGE analyses of enriched secretory lysosomes reveal heterogeneous profiles of functionally relevant proteins in leukemic and activated human NK cells. Schmidt H; Gelhaus C; Nebendahl M; Lettau M; Watzl C; Kabelitz D; Leippe M; Janssen O Proteomics; 2008 Jul; 8(14):2911-25. PubMed ID: 18655029 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]